SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

Kirchhof, P; Lip, GY; Van Gelder, IC; Bax, J; Hylek, E; Kaab, S; Schotten, U; Wegscheider, K; Boriani, G; Brandes, A; et al. Kirchhof, P; Lip, GY; Van Gelder, IC; Bax, J; Hylek, E; Kaab, S; Schotten, U; Wegscheider, K; Boriani, G; Brandes, A; Ezekowitz, M; Diener, H; Haegeli, L; Heidbuchel, H; Lane, D; Mont, L; Willems, S; Dorian, P; Aunes-Jansson, M; Blomstrom-Lundqvist, C; Borentain, M; Breitenstein, S; Brueckmann, M; Cater, N; Clemens, A; Dobrev, D; Dubner, S; Edvardsson, NG; Friberg, L; Goette, A; Gulizia, M; Hatala, R; Horwood, J; Szumowski, L; Kappenberger, L; Kautzner, J; Leute, A; Lobban, T; Meyer, R; Millerhagen, J; Morgan, J; Muenzel, F; Nabauer, M; Baertels, C; Oeff, M; Paar, D; Polifka, J; Ravens, U; Rosin, L; Stegink, W; Steinbeck, G; Vardas, P; Vincent, A; Walter, M; Breithardt, G; Camm, AJ (2012) Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. EUROPACE, 14 (1). 8 - 27 (20). ISSN 1099-5129 https://doi.org/10.1093/europace/eur241
SGUL Authors: Camm, Alan John

Full text not available from this repository.
Item Type: Article
Additional Information: PubMed ID: 21791573
Keywords: atrial fibrillation, management, outcomes, antithrombotic therapy, rate control, rhythm control, risk factors, early therapy, Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, atrial fibrillation, management, outcomes, antithrombotic therapy, rate control, rhythm control, risk factors, early therapy, C-REACTIVE PROTEIN, RADIOFREQUENCY CATHETER ABLATION, GLOMERULAR-FILTRATION-RATE, CARDIOLOGY WORKING GROUP, LONG-QT SYNDROME, CARDIOVASCULAR INTERVENTIONS EAPCI, VENTRICULAR SYSTOLIC DYSFUNCTION, LOBAR INTRACEREBRAL HEMORRHAGE, CEREBRAL AMYLOID ANGIOPATHY, STERILE PERICARDITIS MODEL, Animals, Anti-Arrhythmia Agents, Atrial Fibrillation, Biological Markers, Female, Fibrinolytic Agents, Humans, Male, Rats, Risk Reduction Behavior, Treatment Outcome
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Cardiac (INCCCA)
Journal or Publication Title: EUROPACE
ISSN: 1099-5129
Related URLs:
Dates:
DateEvent
1 January 2012Published
Web of Science ID: WOS:000299351100004
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
URI: https://openaccess.sgul.ac.uk/id/eprint/100624
Publisher's version: https://doi.org/10.1093/europace/eur241

Actions (login required)

Edit Item Edit Item